References

1. Oster, S.K.; Ho, C.S.; Soucie, E.L.; Penn, L.Z. The MYC oncogene: Marvelously complex. Adv. Cancer Res. 2002, 84, 81-154.

2. Pelengaris, S.; Khan, M.; Evan, G. c-MYC: More than just a matter of life and death. Nat. Rev. Cancer 2002, 2, 764776.

3. Claassen, G.F.; Hann, S.R. MYC-mediated transformation: The repression connection. Oncogene 1999, 18, 29252933.

4. Brodeur, G.M. Neuroblastoma: Biological insights into a clinical enigma. Nat. Rev. Cancer 2003, 3, 203-216.

5. Scheurlen, W.G.; Schwabe, G.C.; Joos, S.; Mollenhauer, J.; Sorensen, N.; Kühl, J. Molecular analysis of childhood primitive neuroectodermal tumors defines markers associated with poor outcome. J. Clin. Oncol. 1998, 16, 24782485.

6. Herms, J.; Neidt, I.; Lüscher, B.; Sommer, A.; Schürmann, P.; Schröder, T.; Bergmann, M.; Wilken, B.; Probst-Cousin, S.; Hernaiz-Driever, P.; Behnke, J.; Hanefeld, F.; Pietsch, T.; Kretzschmar, H.A. C-MYC expression in medulloblastoma and its prognostic value. Int. J. Cancer 2000, 89, 395-402.

7. Batra, S.K.; Rasheed, B.K.; Bigner, S.H.; Bigner, D.D. Oncogenes and anti-oncogenes in human central nervous system tumors. Lab. Invest. 1994, 71, 621-637.

8. Grotzer, M.A.; Hogarty, M.D.; Janss, A.J.; Liu, X.; Eggert, A.; Sutton, L.N.; Rorke, L.B.; Brodeur, G.M.; Phillips, P.C. MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma. Clin. Cancer Res. 2001, 7, 2425-2433.

9. Bruggers, C.S.; Tai, K.F.; Murdock, T.; Sivak, L.; Le, K.; Perkins, S.L.; Coffin, C.M.; Caroll, W.L. Expression of the c-myc protein in childhood medulloblastoma. J. Pediatr. Hematol./Oncol. 1998, 20, 18 -25.

10. Bigner, S.H.; Friedman, H.S.; Vogelstein, B.; Oakes, W.J.; Bigner, D.D. Amplification of the c-myc gene in human medulloblastoma cell lines and xenografts. Cancer Res. 1990, 50, 2347-2350.

11. Nesbit, C.E.; Tersak, J.M.; Prochownik, E.V. MYC oncogene and human neoplastic disease. Oncogene 1999, 18, 3004-3016.

12. Hamilton, S.R.; Liu, B.; Parsons, R.E.; Papadopoulos, N. Jen, J.; Powell, S.M.; Krush, A.J.; Berk, T.; Cohen, Z. Tetu, B.; Burger, P.C.; Wood, P.A.; Taqi, F.; Booker, S.V. Peterson, G.M.; Offenhaus, G.J.A.; Tersmette, A.C. Giardiello, F.M.; Vogelstein, B.; Kinzler, K.W. The molecular basis of Turcot's syndrome. N. Engl. J. Med. 1995, 332, 839-847.

13. Yong, W.H.; Raffel, C.; von Deimling, A.; Louis, D.N. The APC gene in Turcot's syndrome. N. Engl. J. Med. 1995, 333, 524.

14. Mori, T.; Nagase, H.; Horii, A.; Miyoshi, Y.; Shimano, T. Nakatsuru, S.; Aoki, T.; Arakawa, H.; Yanagisawa, A. Ushio, Y.; Takano, S.; Ogawa, M.; Nakamura, M. Shibuya, M.; Nishikawa, R.; Matsutani, M.; Hayashi, Y. Takahashi, H.; Ikuta, F.; Nishihira, T.; Mori, S.; Nakamura, Y. Germ-line and somatic mutations of the APC gene in patients with Turcot syndrome and analysis of APC mutations in brain tumors. Genes Chromosomes Cancer 1994, 9, 168-172.

15. Zurawel, R.H.; Chiappa, S.A.; Allen, C.; Raffel, C. Sporadic medulloblastomas contain oncogenic beta-cate-nin mutations. Cancer Res. 1998, 58, 896-899.

16. Eberhart, C.G.; Tihan, T.; Burger, P.C. Nuclear localization and mutation of beta-catenin in medulloblastomas. J. Neuropathol. Exp. Neurol. 2000, 59, 333-337.

17. He, T.C.; Sparks, A.B.; Rago, C.; Hermeking, H.; Zawel, L.; da costa, L.T.; Morin, P.J.; Vogelstein, B.; Kinzler, K.W. Identification of c-MYC as a target of the APC pathway. Science 1998, 281, 1509-1512.

18. Bullions, L.C.; Levine, A.J. The role of beta-catenin in cell adhesion, signal transduction, and cancer. Curr. Opin. Oncol. 1998, 10, 81 -87.

19. Janss, A.J.; Yachnis, A.T.; Silber, J.H.; Trojanowski, J.Q.; Lee, V.M.; Sutton, L.N.; Perilongo, G.; Rorke, L.B.; Phillips, P.C. Glial differentiation predicts poor clinical outcome in primitive neuroectodermal brain tumors. Ann. Neurol. 1996, 39, 481-489.

20. Grotzer, M.A.; Geoerger, B.; Janss, A.J.; Zhao, H.; Rorke, L.B.; Phillips, P.C. Prognostic significance of Ki-67 (MIB-1) proliferation index in childhood primitive neuro-ectodermal tumors of the central nervous system. Med. Pediatr. Oncol. 2001, 36, 268-273.

21. Grotzer, M.A.; Janss, A.J.; Fung, K.-M.; Biegel, J.A.; Sutton, L.N.; Rorke, L.B.; Zhao, H.; Cnaan, A.; Phillips, P.C.; Lee, V.M.-Y.; Trojanowski, J.Q. TrkC expression predicts good clinical outcome in primitive neuroecto-dermal brain tumors. J. Clin. Oncol. 2000, 18, 1027-1035.

22. Kim, J.Y.; Sutton, M.E.; Lu, D.J.; Cho, T.A.; Goumnerova, L.C.; Goritchenko, L.; Kaufman, J.R.; Lam, K.K.; Billet,

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook


Post a comment